Drug Shortage Report for TARO-CLARITHROMYCIN
| Report ID | 169405 |
| Drug Identification Number | 02390450 |
| Brand name | TARO-CLARITHROMYCIN |
| Common or Proper name | CLARITHROMYCIN |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLARITHROMYCIN |
| Strength(s) | 250MG |
| Dosage form(s) | GRANULES FOR SUSPENSION |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 105 |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-24 |
| Estimated end date | 2023-10-27 |
| Actual end date | 2023-12-20 |
| Shortage status | Resolved |
| Updated date | 2024-01-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.